logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Intercontinental Oil and Gas: Currently, the company's main product in the producing blocks is crude oil, with no natural gas reserves.

date
17/03/2026
Intercontinental Oil and Gas stated on the interactive platform on March 17 that the company's main product in the production area is crude oil, and there is no natural gas reserve.
Latest
5 m ago
Sunac China: It is expected that the company's net loss attributable to owners will be between 12 billion to 13 billion yuan by 2025.
5 m ago
Sunac China: Net loss significantly reduced year-on-year.
5 m ago
Beijing launches "Clear Skies and Bright Future AI for Good" special campaign to focus on rectifying five types of network chaos in the field of AI.
6 m ago
Parker New Materials: Net profit in 2025 is 252 million yuan, a year-on-year decrease of 4.37%
6 m ago
According to the AI Fast News of Every Economics, Open Source Securities released a research report on March 17th, giving Punong Medical (920069.SH) a "hold" rating. The reasons for the rating mainly include: 1) Punong Medical: The insulin pen needle "Little Giant" is scarce, developing minimally invasive intervention in the second curve; 2) Industry: The diabetes injection market is stable and growing, and the extension of new businesses in the puncture instrument scene; 3) Company highlights: leading market share, strong technology, good customers, with a comparable company PE 2024 average of 53X. (Everyday Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.